HM Payson & Co’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,273
| Closed | -$9.22K | – | 1018 |
|
2023
Q3 | $9.22K | Hold |
1,273
| – | – | ﹤0.01% | 831 |
|
2023
Q2 | $9.46K | Buy |
1,273
+65
| +5% | +$483 | ﹤0.01% | 810 |
|
2023
Q1 | $8.37K | Hold |
1,208
| – | – | ﹤0.01% | 813 |
|
2022
Q4 | $12.4K | Hold |
1,208
| – | – | ﹤0.01% | 727 |
|
2022
Q3 | $22K | Hold |
1,208
| – | – | ﹤0.01% | 684 |
|
2022
Q2 | $62K | Hold |
1,208
| – | – | ﹤0.01% | 550 |
|
2022
Q1 | $89K | Hold |
1,208
| – | – | ﹤0.01% | 513 |
|
2021
Q4 | $173K | Buy |
1,208
+9
| +0.8% | +$1.29K | ﹤0.01% | 423 |
|
2021
Q3 | $249K | Sell |
1,199
-200
| -14% | -$41.5K | 0.01% | 364 |
|
2021
Q2 | $297K | Hold |
1,399
| – | – | 0.01% | 338 |
|
2021
Q1 | $254K | Hold |
1,399
| – | – | 0.01% | 363 |
|
2020
Q4 | $156K | Buy |
1,399
+4
| +0.3% | +$446 | ﹤0.01% | 427 |
|
2020
Q3 | $151K | Hold |
1,395
| – | – | ﹤0.01% | 399 |
|
2020
Q2 | $116K | Buy |
1,395
+195
| +16% | +$16.2K | ﹤0.01% | 419 |
|
2020
Q1 | $16K | Buy |
+1,200
| New | +$16K | ﹤0.01% | 682 |
|